Newest figures come from the 10-Q for Q1 FY2027, filed Nov 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MWAI SEC filings page.
Medwellai Inc (MWAI) reported $528K in revenue for fiscal year 2026, down 11.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
MWAI’s asset base has collapsed beneath expanding liabilities, while revenue remains too small to absorb operating losses.
From FY2023 to FY2026, total assets fell97.9% while total liabilities rose14.4% , so obligations did not contract with the asset base. By FY2026, liabilities equaled5781.4% of assets and the current ratio was 0.0141, indicating a balance sheet dominated by claims due relative to recorded resources.
Reported operating cash flow of
Operating margin improved to
Financial Health Signals
We do not publish a peer-relative financial health score for Medwellai Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Medwellai Inc passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.
Medwellai Inc reported an operating loss of $1.2M against $52K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Medwellai Inc generated $76K in revenue in Q1 2027. This represents a decrease of 34.9% from the same quarter a year earlier.
Medwellai Inc's EBITDA was -$240K in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Medwellai Inc reported a net loss of $287K in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Medwellai Inc earned -$0.04 per diluted share (EPS) in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Medwellai Inc held $180K in cash as of Q1 2027; no long-term debt figure is on record for that period.
Not reported for Q1 2027.
Not reported for Q1 2027.
Margins & Returns
Medwellai Inc's gross margin was 100.0% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 6.4 percentage points from the same quarter a year earlier.
Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q1 2027: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q1 2027.
Capital Allocation
None of these metrics is reported for Q1 2027.
MWAI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76K-34.9% | N/A | $619K+119.9% | $548K+283.8% | $117K+10125.3% | $169K-84.5% | $281K-85.8% | $143K-91.7% |
| Cost of Revenue | $0-100.0% | N/A | N/A | N/A | $8Kn/m | N/A | $0-100.0% | $0-100.0% |
| Gross Profit | $76K-30.5% | N/A | N/A | N/A | $110K+9467.7% | N/A | $281K-64.2% | $143K-74.3% |
| SG&A Expenses | $316K-29.3% | N/A | $365K-67.7% | $410K-34.4% | $447K+33.4% | $595K+65.3% | $1.1M+370.6% | $625K+227.4% |
| Operating Income | -$246Kn/m | N/A | -$228Kn/m | -$274Kn/m | -$327Kn/m | -$1.1Mn/m | -$814K-354.1% | -$315Kn/m |
| EBITDA | -$240Kn/m | N/A | -$213Kn/m | -$259K-367.7% | -$319Kn/m | -$1.1Mn/m | -$795K-178.5% | $97K-76.4% |
| Interest Expense | $46K+255.1% | N/A | $13K+0.5% | $14K+4.9% | $13K-0.9% | $14K+4.3% | $13K-45.4% | $13K-45.6% |
| Income Tax | $0n/m | N/A | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Net Income | -$287Kn/m | N/A | -$240Kn/m | -$288Kn/m | -$652Kn/m | -$1.1Mn/m | -$589K-298.0% | -$674Kn/m |
| EPS (Basic) | -$0.04n/m | -$0.06n/m | -$0.04n/m | -$0.05n/m | -$0.10n/m | -$0.18n/m | -$0.10 | -$0.14n/m |
| EPS (Diluted) | -$0.04n/m | -$0.06n/m | -$0.04n/m | -$0.05n/m | -$0.10n/m | -$0.18n/m | -$0.10 | -$0.13n/m |
| Diluted Shares (Avg) | N/A | N/A | N/A | N/A | N/A | N/A | 6M | 5M+25.7% |
Not reported in any period shown, so not listed: R&D Expenses.
MWAI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $221K-59.9% | $140K-82.6% | $322K-83.0% | $461K-83.6% | $550K-84.0% | $806K-79.6% | $1.9M-68.2% | $2.8M-48.3% |
| Current Assets | $198K-18.0% | $112K-73.3% | $165K-78.5% | $164K-89.1% | $242K-86.3% | $419K-83.9% | $766K-62.0% | $1.5M+4681.1% |
| Cash & Equivalents | $180K-19.3% | $86K-78.5% | $130K-73.0% | $138K-41.4% | $223K-70.2% | $401K+594.1% | $482K+26.3% | $235K+754.3% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $3K | $9K | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | $670K | $670K |
| Total Liabilities | $8.5M+9.1% | $8.1M+9.3% | $8.0M+7.7% | $7.9M-4.3% | $7.8M-6.0% | $7.4M-4.8% | $7.4M+0.1% | $8.3M+15.7% |
| Current Liabilities | $8.3M+10.6% | $8.0M+160.5% | $7.8M+157.8% | $7.7M+101.9% | $7.5M+101.5% | $3.1M-17.0% | $3.0M-8.8% | $3.8M+25.7% |
| Non-Current Liabilities | $156K-35.7% | $161K-96.3% | $231K-94.8% | $237K-94.7% | $243K-94.6% | $4.4M+6.0% | $4.4M+7.2% | $4.5M+8.3% |
| Total Equity | -$8.3Mn/m | -$8.0Mn/m | -$7.7Mn/m | -$7.5Mn/m | -$7.2Mn/m | -$6.6Mn/m | -$5.5Mn/m | -$5.5Mn/m |
| Retained Earnings | -$90.6Mn/m | -$90.3Mn/m | -$89.9M-202.6% | -$89.6Mn/m | -$89.3Mn/m | -$88.7Mn/m | $87.5Mn/m | -$87.0Mn/m |
Not reported in any period shown, so not listed: Inventory, Long-Term Debt.
MWAI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$101Kn/m | -$44Kn/m | -$7Kn/m | -$85Kn/m | -$171Kn/m | -$109Kn/m | -$278Kn/m | -$217Kn/m |
| Depreciation & Amortization | $6K-26.3% | $9K+57.9% | $15K-23.4% | $15K-96.5% | $8K+197.5% | $5K-99.2% | $19K-97.3% | $412K-44.7% |
| Stock-Based Compensation | $0-100.0% | N/A | N/A | N/A | $49Kn/m | N/A | N/A | N/A |
| Capital Expenditures | N/A | $0n/m | $0n/m | N/A | N/A | $0n/m | $0n/m | $0-100.0% |
| Free Cash Flow | N/A | -$44Kn/m | -$7Kn/m | N/A | N/A | -$109Kn/m | -$278Kn/m | -$217Kn/m |
| Investing Cash Flow | $0n/m | $0-100.0% | $0-100.0% | -$750n/m | -$7K-100.8% | $28K-95.7% | $526K-61.4% | -$299K-121.6% |
| Financing Cash Flow | $195Kn/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
MWAI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0%+6.4pp | N/A | N/A | N/A | 93.6%-6.4pp | N/A | 100.0%+60.4pp | 100.0%+67.8pp |
| Operating Margin | -321.9% | N/A | -36.8% | -50.0% | -278.8% | -662.4% | -289.4% | -220.6% |
| Net Margin | -375.9% | N/A | -38.8% | -52.4% | -555.3% | -666.0% | -209.2% | -471.7% |
| Return on Assets | -130.2%-11.7pp | N/A | -74.7%-43.6pp | -62.4%-38.5pp | -118.5%-83.2pp | -140.1%-79.7pp | -31.1%-36.1pp | -23.9%-17.3pp |
| Current Ratio | 0.020.0x | 0.01-0.1x | 0.02-0.2x | 0.02-0.4x | 0.03-0.4x | 0.14-0.6x | 0.25-0.4x | 0.40+0.4x |
| Asset Turnover | 0.35+0.1x | N/A | 1.92+1.8x | 1.19+1.1x | 0.21+0.2x | 0.21-0.1x | 0.15-0.2x | 0.05-0.3x |
| FCF Margin | N/A | N/A | -1.2%+97.7pp | N/A | N/A | -64.2%+20.8pp | -98.9%-52.8pp | -151.7% |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$8.0M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Medwellai Inc MWAI | FY2026 | $528K | -$1.6M | N/A | N/A | — |
| FDCTech Inc FDCT | FY2025 | $35.0M | $5.8M | 16.6% | $501.3M | — |
| NetBrands Corp NBND | FY2025 | $18K | -$1.7M | N/A | $375K | — |
| Hawkeye Digital Inc HWKE | FY2026 | $0 | -$573K | N/A | $231.5M | — |
Where Medwellai Inc Ranks
Frequently Asked Questions
Medwellai Inc (MWAI) reported $528K in total revenue for fiscal year 2026. This represents a -11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Medwellai Inc (MWAI) revenue declined by 11.2% year-over-year, from $595K to $528K in fiscal year 2026.
No, Medwellai Inc (MWAI) reported a net loss of $1.6M in fiscal year 2026.
Medwellai Inc (MWAI) had EBITDA of -$1.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
Medwellai Inc (MWAI) recorded an outflow of $307K in free cash flow during fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Medwellai Inc (MWAI) recorded an outflow of $307K in operating cash flow during fiscal year 2026, representing cash used by core business activities.
Medwellai Inc (MWAI) had $140K in total assets as of fiscal year 2026, including both current and long-term assets.
Medwellai Inc (MWAI) reported no capital expenditure during fiscal year 2026.
Medwellai Inc (MWAI) had a current ratio of 0.01 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.
Medwellai Inc (MWAI) had a return on assets of -1131.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Medwellai Inc (MWAI) has negative shareholder equity of -$8.0M as of fiscal year 2026, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Medwellai Inc (MWAI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Medwellai Inc (MWAI) reported an operating loss of $1.2M against $52K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.